Article Versions Notes

Lebrat M, Bouattour Y, Gaudet C, Yessaad M, Jouannet M, Wasiak M, Dhifallah I, Beyssac E, Garrait G, Chennell P, et al. Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics. 2023; 15(3):755. https://doi.org/10.3390/pharmaceutics15030755

Lebrat, Matthieu, Yassine Bouattour, Coralie Gaudet, Mouloud Yessaad, Mireille Jouannet, Mathieu Wasiak, Imen Dhifallah, Eric Beyssac, Ghislain Garrait, Philip Chennell, and et al. 2023. "Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation" Pharmaceutics 15, no. 3: 755. https://doi.org/10.3390/pharmaceutics15030755

Lebrat, M., Bouattour, Y., Gaudet, C., Yessaad, M., Jouannet, M., Wasiak, M., Dhifallah, I., Beyssac, E., Garrait, G., Chennell, P., & Sautou, V. (2023). Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Pharmaceutics, 15(3), 755. https://doi.org/10.3390/pharmaceutics15030755